Exclusive

Publication

Byline

Cordex expands Zemcelpro access to Hong Kong and Singapore for stem cell transplantation

Singapore, July 17 -- Canada-based ExCellThera Inc., a global leader in blood stem cell expansion and metabolic fitness technologies and parent company of Cordex Biologics, has announced that Cordex h... Read More


Samsung Bioepis and Organon expand biosimilar commercialisation agreement in Australia

Singapore, July 17 -- US-based Organon, a global healthcare company with deep expertise in biosimilars, and Korea's Samsung Bioepis have announced the expansion of their development and commercialisat... Read More


Burjeel Medical City and Roswell Park to establish specialised thoracic surgery programme in Abu Dhabi

Singapore, July 17 -- Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, has entered into a clinical and academic collaboration with New York-based Roswell Park Comprehensive Cance... Read More


Telix opens Australian-first facility to accelerate delivery of new cancer treatments

Singapore, July 16 -- Telix Pharmaceuticals has officially opened a multi-million dollar radiopharmaceutical research, manufacturing and treatment facility in Melbourne, expanding and strengthening Au... Read More


Japan's GHIT injects $18 M in Malaria, Tuberculosis and NTD R&D projects

Singapore, July 16 -- The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 2.86 billion ($18 million) in six R&D projects for the development of dr... Read More


Insilico Medicine partners with Taiwan's Bora Pharma for AI-driven drug discovery

Singapore, July 16 -- Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has announced a multi-target strategic alliance with Ta... Read More


CEPI, University of Oxford and Serum Institute of India launch trials for Bundibugyo ebolavirus vaccine

Singapore, July 16 -- A CEPI-backed vaccine candidate developed by the University of Oxford's Oxford Vaccine Group has become the first Bundibugyo ebolavirus vaccine to enter Phase 1 clinical trials, ... Read More


Singapore to expand wearable technology for patient monitoring following successful pilot

Singapore, July 16 -- The National University Hospital (NUH) in Singapore is set to expand the use of wearable technology after a successful pilot found that continuous smartwatch-based monitoring cou... Read More


GEM and Senhwa Biosciences execute share purchase agreement for up to NT$500 M

Singapore, July 15 -- US-based GEM Global Yield LLC SCS has executed a Share Purchase Agreement (SPA) with the existing shareholders of Taiwan-listed Senhwa Biosciences Inc., under which GEM has commi... Read More


Singapore pledges $2 M to support Ebola response in DR Congo and Uganda

Singapore, July 14 -- Singapore will contribute $2 million to support the ongoing Ebola Bundibugyo Virus Disease (BVD) outbreak response in the Democratic Republic of the Congo (DRC) and Uganda. The c... Read More